L04TD2
- Generic Name
- L04TD2
A Bioequivalence Study of L04TD2 Compared to Administration of L04RD1 in Healthy Volunteers
- First Posted Date
- 2022-10-14
- Last Posted Date
- 2023-01-12
- Lead Sponsor
- Celltrion
- Target Recruit Count
- 50
- Registration Number
- NCT05581693
- Locations
- 🇰🇷
Jaewoo Kim, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath